Compare Expensify Inc (EXFY) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expensify Inc vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Expensify Inc trades at $2.39 (market cap $208.82M), while Halozyme Therapeutics Inc. Common Stock trades at $111.12 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 60.2× Expensify Inc's market cap, and Expensify Inc is more actively traded (456,102 versus 2,179,278). Which is the better fit depends on your goals — on Pluang, investors hold Expensify Inc for 41 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| EXFY | HALO | |
|---|---|---|
Market Cap | $208.82M | $12.58B |
Volume | 456,102 | 2,179,278 |
Sector | Technology | Health |
52-Week High | $2.72 | $115.22 |
52-Week Low | $0.75 | $61.63 |
Typical Hold Time | 41 Days | 1 Days |
Enterprise Value | $148.44M | $14.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Expensify (EXFY) trades at $2.40, up 5.73% today, showing technical bullish momentum with positive moving averages. The company reported mixed quarterly results with recent beats but maintains negative profitability metrics. Recent business developments include strategic AI integrations and European expansion of its corporate card program, signaling growth initiatives despite ongoing net losses.
The outlook remains speculative with analyst consensus pointing to significant upside potential ($13.75 target) but fundamental challenges persist including negative margins and cash flow volatility. Key risks include execution on AI transition and competitive pressure in expense management software, while institutional sentiment leans bullish with 50% buy ratings.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Expensify Inc
Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
Read more on EXFY →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
